Literature DB >> 33742731

Fecal microbiota transplantation ameliorates gut microbiota imbalance and intestinal barrier damage in rats with stress-induced depressive-like behavior.

Jingjing Rao1, Ruining Xie2, Li Lin2, Jian Jiang2, Lei Du2, Xindie Zeng2, Gongying Li3, Chunmei Wang4, Yi Qiao2.   

Abstract

The gut-microbiota-brain axis is the most important complex and bidirectional pathway between the gastrointestinal tract and the central nervous system. This study investigated the potential of microbe-induced gut-to-brain signaling to modulate the effect of stress on depressive-like behavior, intestinal barrier, and neuroinflammation. Result showed that fecal microbiota transplantation increased the consumption of sucrose solutions and decreased the immobility time in forced swimming test. This treatment also increased Firmicutes and decreased Bacteroidetes and Desulfobacterota at phylum levels; reduced the loss of villi and epithelial cells; suppressed the inflammatory cell infiltration in the ileum; increased the expression of ZO-1, occludin; protected the mucosal layer function; and suppressed the high levels of inflammasomes (NLRP3, ASC, caspase-1, and IL-1β) in rat brain. In summary, fecal microbiota transplantation improves the depressive-like behavior, alters the gut microbiota imbalance, and alleviates the intestinal tract inflammation, intestinal mucosa disruption, and neuroinflammation in rats induced by chronic unpredictable mild stress.
© 2021 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  depression; fecal microbiota transplantation; gut mucosa barrier; gut-microbiota-brain axis; inflammation

Year:  2021        PMID: 33742731     DOI: 10.1111/ejn.15192

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  8 in total

1.  Multi-omic Analysis of the Gut Microbiome in Rats with Lithium-Pilocarpine-Induced Temporal Lobe Epilepsy.

Authors:  Maria Eduarda T Oliveira; Gustavo V B Paulino; Erivaldo D Dos Santos Júnior; Francisca A da Silva Oliveira; Vânia M M Melo; Jeferson S Ursulino; Thiago M de Aquino; Ashok K Shetty; Melissa Fontes Landell; Daniel Leite Góes Gitaí
Journal:  Mol Neurobiol       Date:  2022-08-13       Impact factor: 5.682

2.  Effects of Chang-Kang-Fang Formula on the Microbiota-Gut-Brain Axis in Rats With Irritable Bowel Syndrome.

Authors:  Xiwen Ling; Siyuan Peng; Jingbin Zhong; Lirong Guo; Yaqin Xu; Xiaobao Jin; Fujiang Chu
Journal:  Front Pharmacol       Date:  2022-05-09       Impact factor: 5.988

3.  The Role of the Gut Microbiota in the Development and Progression of Major Depressive and Bipolar Disorder.

Authors:  Tom Knuesel; M Hasan Mohajeri
Journal:  Nutrients       Date:  2021-12-23       Impact factor: 5.717

4.  Jasmine Tea Attenuates Chronic Unpredictable Mild Stress-Induced Depressive-like Behavior in Rats via the Gut-Brain Axis.

Authors:  Yangbo Zhang; Jianan Huang; Yifan Xiong; Xiangna Zhang; Yong Lin; Zhonghua Liu
Journal:  Nutrients       Date:  2021-12-27       Impact factor: 5.717

Review 5.  Crosstalk between adipose tissue and the microbiota-gut-brain axis in metabolic diseases.

Authors:  Ziwei Yu; Yuting Wang; Zhi Yu; Mengjiang Lu; Bin Xu
Journal:  Int J Biol Sci       Date:  2022-02-07       Impact factor: 6.580

6.  Dietary ellagic acid ameliorated Clostridium perfringens-induced subclinical necrotic enteritis in broilers via regulating inflammation and cecal microbiota.

Authors:  Yu Tang; Xinyue Zhang; Yanan Wang; Yongpeng Guo; Peiqi Zhu; Guiguan Li; Jianyun Zhang; Qiugang Ma; Lihong Zhao
Journal:  J Anim Sci Biotechnol       Date:  2022-04-19

7.  Therapeutic effect of fecal microbiota transplantation on chronic unpredictable mild stress-induced depression.

Authors:  Ting Cai; Shao-Peng Zheng; Xiao Shi; Ling-Zhi Yuan; Hai Hu; Bai Zhou; Shi-Lang Xiao; Fen Wang
Journal:  Front Cell Infect Microbiol       Date:  2022-07-28       Impact factor: 6.073

Review 8.  New hope for Parkinson's disease treatment: Targeting gut microbiota.

Authors:  Hong-Xia Fan; Shuo Sheng; Feng Zhang
Journal:  CNS Neurosci Ther       Date:  2022-07-13       Impact factor: 7.035

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.